 Andrew Libby
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipid Metabolism | 5 | 2025 | 503 | 1.280 |
Why?
| | Perilipin-2 | 3 | 2019 | 41 | 1.270 |
Why?
| | Adipose Tissue, White | 3 | 2024 | 37 | 1.000 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2022 | 260 | 0.980 |
Why?
| | Ovariectomy | 1 | 2024 | 135 | 0.840 |
Why?
| | Rats, Wistar | 1 | 2024 | 442 | 0.800 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 237 | 0.800 |
Why?
| | Estradiol | 1 | 2024 | 494 | 0.690 |
Why?
| | Triglycerides | 3 | 2025 | 528 | 0.650 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2020 | 133 | 0.630 |
Why?
| | Adipose Tissue, Brown | 2 | 2022 | 51 | 0.620 |
Why?
| | Lipoprotein Lipase | 2 | 2018 | 59 | 0.620 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 217 | 0.610 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 62 | 0.590 |
Why?
| | Energy Metabolism | 1 | 2024 | 875 | 0.590 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 479 | 0.560 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 57 | 0.530 |
Why?
| | Gene Deletion | 1 | 2018 | 382 | 0.520 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.520 |
Why?
| | Liver | 3 | 2024 | 1842 | 0.500 |
Why?
| | Apolipoproteins | 1 | 2015 | 38 | 0.490 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 138 | 0.480 |
Why?
| | Temperature | 1 | 2018 | 637 | 0.470 |
Why?
| | Hypothalamus | 1 | 2015 | 149 | 0.460 |
Why?
| | Kidney | 3 | 2023 | 1386 | 0.330 |
Why?
| | Neurons | 1 | 2015 | 1494 | 0.260 |
Why?
| | Fatty Acid Synthase, Type I | 1 | 2025 | 11 | 0.240 |
Why?
| | Mice | 11 | 2023 | 16961 | 0.230 |
Why?
| | Animals | 14 | 2024 | 35391 | 0.230 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 2 | 2022 | 15 | 0.230 |
Why?
| | Cholesterol | 3 | 2022 | 412 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2022 | 1167 | 0.210 |
Why?
| | Hepatitis, Autoimmune | 1 | 2023 | 20 | 0.210 |
Why?
| | Diet, Western | 2 | 2022 | 79 | 0.210 |
Why?
| | Endogenous Retroviruses | 1 | 2023 | 34 | 0.200 |
Why?
| | Fatty Liver | 2 | 2022 | 230 | 0.200 |
Why?
| | Ovary | 1 | 2024 | 209 | 0.200 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 195 | 0.190 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 88 | 0.190 |
Why?
| | Liver X Receptors | 1 | 2020 | 31 | 0.180 |
Why?
| | Leptin | 1 | 2022 | 220 | 0.180 |
Why?
| | Adipocytes | 2 | 2022 | 204 | 0.180 |
Why?
| | Anions | 1 | 2020 | 31 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 752 | 0.170 |
Why?
| | Liver Diseases | 1 | 2023 | 290 | 0.170 |
Why?
| | Body Composition | 1 | 2024 | 649 | 0.170 |
Why?
| | Reperfusion Injury | 1 | 2022 | 272 | 0.160 |
Why?
| | Body Weight | 1 | 2024 | 940 | 0.160 |
Why?
| | Obesity | 4 | 2022 | 2882 | 0.160 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.160 |
Why?
| | Retroviridae | 2 | 2018 | 99 | 0.160 |
Why?
| | Microscopy, Fluorescence | 1 | 2020 | 399 | 0.150 |
Why?
| | Rats | 2 | 2024 | 5483 | 0.150 |
Why?
| | Thermogenesis | 1 | 2018 | 44 | 0.150 |
Why?
| | Muscle, Striated | 1 | 2018 | 5 | 0.150 |
Why?
| | Lipogenesis | 1 | 2018 | 59 | 0.140 |
Why?
| | Transcriptome | 1 | 2024 | 876 | 0.140 |
Why?
| | Genetic Vectors | 2 | 2018 | 314 | 0.140 |
Why?
| | Hepatocytes | 1 | 2019 | 216 | 0.140 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 169 | 0.130 |
Why?
| | Metabolic Diseases | 1 | 2018 | 104 | 0.130 |
Why?
| | Mice, Knockout | 3 | 2022 | 2881 | 0.130 |
Why?
| | Lactation | 1 | 2018 | 175 | 0.130 |
Why?
| | Kidney Diseases | 1 | 2020 | 383 | 0.130 |
Why?
| | Intracellular Membranes | 1 | 2016 | 83 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 169 | 0.130 |
Why?
| | Dietary Fats | 1 | 2018 | 301 | 0.130 |
Why?
| | Learning | 1 | 2020 | 407 | 0.120 |
Why?
| | Genetic Therapy | 1 | 2018 | 289 | 0.120 |
Why?
| | Agouti-Related Protein | 1 | 2015 | 2 | 0.120 |
Why?
| | Lipid Droplets | 1 | 2015 | 22 | 0.120 |
Why?
| | Inflammation | 2 | 2023 | 2750 | 0.120 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 141 | 0.120 |
Why?
| | Breast Feeding | 1 | 2018 | 423 | 0.110 |
Why?
| | Biological Transport | 1 | 2015 | 404 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2016 | 261 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1001 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2022 | 5455 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2133 | 0.100 |
Why?
| | Glucose | 3 | 2022 | 1002 | 0.090 |
Why?
| | Insulin | 1 | 2022 | 2326 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 605 | 0.090 |
Why?
| | Adipose Tissue | 3 | 2022 | 591 | 0.090 |
Why?
| | Diet | 1 | 2018 | 1213 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1465 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2542 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2442 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 239 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 3968 | 0.070 |
Why?
| | Humans | 9 | 2025 | 129625 | 0.070 |
Why?
| | Cytokines | 2 | 2023 | 2021 | 0.060 |
Why?
| | Tamoxifen | 1 | 2025 | 197 | 0.060 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2025 | 155 | 0.050 |
Why?
| | Female | 4 | 2025 | 68734 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2023 | 41 | 0.050 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 17 | 0.050 |
Why?
| | eIF-2 Kinase | 1 | 2023 | 30 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 18 | 0.050 |
Why?
| | Unfolded Protein Response | 1 | 2023 | 53 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 110 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 47 | 0.050 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2023 | 101 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 84 | 0.050 |
Why?
| | Mice, Obese | 1 | 2022 | 61 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 74 | 0.050 |
Why?
| | Receptors, Estrogen | 1 | 2025 | 422 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| | Glucosides | 1 | 2022 | 38 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 187 | 0.050 |
Why?
| | Signal Transduction | 1 | 2015 | 4931 | 0.050 |
Why?
| | Benzhydryl Compounds | 1 | 2022 | 66 | 0.050 |
Why?
| | Acetylcysteine | 1 | 2022 | 146 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 147 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 264 | 0.050 |
Why?
| | Phospholipids | 1 | 2022 | 216 | 0.040 |
Why?
| | Estrogens | 1 | 2023 | 347 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 207 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 621 | 0.040 |
Why?
| | Adiponectin | 1 | 2022 | 235 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 26 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2023 | 373 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 526 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 117 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 427 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 118 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2022 | 382 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2022 | 772 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1336 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4078 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 723 | 0.040 |
Why?
| | Hypertriglyceridemia | 1 | 2018 | 39 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1202 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3186 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2025 | 2373 | 0.030 |
Why?
| | Milk | 1 | 2018 | 122 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 876 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 460 | 0.030 |
Why?
| | Male | 5 | 2022 | 63670 | 0.030 |
Why?
| | Feces | 1 | 2020 | 442 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 509 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2018 | 622 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 640 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 1970 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 5756 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 731 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2739 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 574 | 0.020 |
Why?
| | Macrophages | 1 | 2019 | 1488 | 0.020 |
Why?
| | Infant | 1 | 2023 | 8995 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 6417 | 0.020 |
Why?
| | Aged | 1 | 2023 | 22061 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|